Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials
Highlights • Brexpiprazole is an adjunctive therapy for treatment of MDD. • Anxiety symptoms are prevalent in MDD and associated